Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study to Evaluate Real-world Clinical Outcomes and Characteristics of Patients With mCRPC Treated With Olaparib + Abiraterone

NCT06380738 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06380738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06380738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study to Evaluate Real-world Clinical Outcomes and Characteristics of Patients With mCRPC Treated With Olaparib + Abiraterone
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
February 14, 2024
Completion date
February 14, 2027
Enrollment
111 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate cancer